FDA presses pause on trial for OTC version of anti-impotence drug Cialis
By Tassilo Hummel and Natalie Grover PARIS/LONDON (Reuters) -The U.S. health regulator has put on hold a trial designed to evaluate switching the prescription-only erectile dysfunction drug Cialis to an over-the-counter (OTC) treatment, French drugmaker Sanofi said on Monday. The pause is related to concerns about how the trial protocol has been designed, the company …
FDA presses pause on trial for OTC version of anti-impotence drug Cialis Read More »









